HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anyanwu, E. Articles by Vogt-Moykopf, I. Search for Related Content PubMed PubMed Citation Articles by Anyanwu, E. Articles by Vogt-Moykopf, I.

The Annals of Thoracic Surgery, Vol 57, 1222-1228, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Pulmonary metastasectomy as secondary treatment for testicular tumors

E Anyanwu, S Krysa, H Buelzebruck and I Vogt-Moykopf
Department of Surgery, Chest Hospital, Heidelberg-Rohrbach, Germany.

Patients presenting with synchronous and metachronous metastases of nonseminomatous testicular tumors are candidates for pulmonary metastasectomy after receiving definitive primary treatment, which includes semicastration, eventually retroperitoneal lymphadenectomy, and definitely chemotherapy. One hundred four such patients (age, 14 to 79 years; median age, 27 years) underwent pulmonary metastasectomy from 1972 to 1990, representing 15.8% of the pulmonary metastasectomies performed during the same period. Of the 117 operations performed, eight were repeat operations. Median sternotomy, posterolateral and, later, transverse thoracotomies were the standard surgical approaches used to remove the single and multiple metastases randomly distributed in both lungs. Wedge resections and atypical segmentectomies (66%), lobectomies (15%), anatomic segmentectomies (9%), pneumonectomies (3%), bilobectomies (3%), and mediastinal lymphadenectomies (65.4%) were the various procedures performed. Of the 104 patients, metastasectomy was complete in 80 and incomplete in 24. The 30-day mortality was 2.0%. Life table analysis revealed a survival rate of 77%, 70%, 66%, and 59% at 1, 2, 3, and 5 years, respectively. Of all prognostic factors examined, complete resection of the metastases seems to be the most significant factor influencing the prognosis.

This article has been cited by other articles:

				K. A. Kesler, J. L. Wilson, J. A. Cosgrove, J. A. Brooks, A. Messiha, N. S. Fineberg, L. H. Einhorn, and J. W. Brown Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: Analysis of a single-institution experience J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 408 - 415. [Abstract] [Full Text] [PDF]

				K. A. Kesler, J. A. Brooks, K. M. Rieger, N. S. Fineberg, L. H. Einhorn, and J. W. Brown Mediastinal metastases from testicular nonseminomatous germ cell tumors: Patterns of dissemination and predictors of long-term survival with surgery J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 913 - 923. [Abstract] [Full Text] [PDF]

				J. B. Zwischenberger and S. K. Alpard Pulmonary metastasectomy Ann. Thorac. Surg., July 1, 1999; 68(1): 287 - 288. [Full Text] [PDF]

				J. H. Robert, V. Ambrogi, B. Mermillod, D. Dahabreh, and P. Goldstraw Factors Influencing Long-Term Survival After Lung Metastasectomy Ann. Thorac. Surg., March 1, 1997; 63(3): 777 - 784. [Abstract] [Full Text]